Pentwater Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Pentwater Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-300,000	Closed	-$95M	–	138
2023 Q4	$95M	Buy	+300,000	New	+$58.3M	1.06%	22
2022 Q3	–	Sell	-37,500	Closed	-$4.74M	–	193
2022 Q2	$4.74M	Buy	37,500 +32,500	+650%	+$3.74M	0.06%	103
2022 Q1	$634K	Buy	+5,000	New	+$563K	0.01%	142

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Pentwater Capital Management's KRTX Position: Q1 2024 in Review

Pentwater Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,066,200 shares — an estimated $337M sold.

Pentwater Capital Management first reported a position in KRTX in Q2 2019 and held it in 19 quarters. The position peaked at $337M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Pentwater Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Pentwater Capital Management sold 1,066,200 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $337M.
Pentwater Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
Pentwater Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $337M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Pentwater Capital Management's 13F filing for Q1 2024, filed 15 May 2024.